Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. [electronic resource]
Producer: 20060921Description: 93-7 p. digitalISSN:- 0169-5002
- Aged
- Antimetabolites, Antineoplastic -- therapeutic use
- Carcinoma, Small Cell -- drug therapy
- Drug Resistance, Neoplasm
- Female
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Recurrence, Local
- Quinazolines -- therapeutic use
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.